TOP MEDICS (UK) LIMITED

Company Registration Number:
05048030 (England and Wales)

Unaudited abridged accounts for the year ended 28 February 2025

Period of accounts

Start date: 29 February 2024

End date: 28 February 2025

TOP MEDICS (UK) LIMITED

Contents of the Financial Statements

for the Period Ended 28 February 2025

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

TOP MEDICS (UK) LIMITED

Company Information

for the Period Ended 28 February 2025




Director: Joseph Chiemeka
Michele Chiemeka
Registered office: Westcroft House
Havelock Street
Bradford
West Yorkshire
England
BD7 4EX
Company Registration Number: 05048030 (England and Wales)

TOP MEDICS (UK) LIMITED

Directors' Report Period Ended 28 February 2025

The directors present their report with the financial statements of the company for the period ended 28 February 2025

Principal Activities

The sale of medical products

Directors

The directors shown below have held office during the whole of the period from 29 February 2024 to 28 February 2025
Joseph Chiemeka
Michele Chiemeka

This report was approved by the board of directors on 16 September 2025
And Signed On Behalf Of The Board By:

Name: Joseph Chiemeka
Status: Director

TOP MEDICS (UK) LIMITED

Balance sheet

As at 28 February 2025


Notes

2025
£

2024
£
Fixed assets
Tangible assets: 4 519,656 508,099
Total fixed assets: 519,656 508,099
Current assets
Stocks: 1,235,950 1,220,609
Debtors: 222,350 141,894
Cash at bank and in hand: 491,623 177,081
Total current assets: 1,949,923 1,539,584
Net current assets (liabilities): 1,949,923 1,539,584
Total assets less current liabilities: 2,469,579 2,047,683
Creditors: amounts falling due after more than one year: ( 1,656,345 ) ( 1,259,299 )
Total net assets (liabilities): 813,234 788,384

The notes form part of these financial statements

TOP MEDICS (UK) LIMITED

Balance sheet continued

As at 28 February 2025


Notes

2025
£

2024
£
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 813,232 788,382
Shareholders funds: 813,234 788,384

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 16 September 2025
And Signed On Behalf Of The Board By:

Name: Joseph Chiemeka
Status: Director

The notes form part of these financial statements

TOP MEDICS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

TOP MEDICS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 2. Employees


    2025

    2024
    Average number of employees during the period 7 5

TOP MEDICS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 3. Off balance sheet disclosure

    No

TOP MEDICS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2025

4. Tangible Assets

Total
Cost £
At 29 February 2024 589,626
Additions 16,969
Disposals -
Revaluations -
Transfers -
At 28 February 2025 606,595
Depreciation
At 29 February 2024 81,527
Charge for year 5,412
On disposals -
Other adjustments -
At 28 February 2025 86,939
Net book value
At 28 February 2025 519,656
At 28 February 2024 508,099